BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37246003)

  • 1. [Factors affecting BK polyomavirus infection after kidney transplantation in post-school children and a predictive infection model].
    Yan YC; Wang ZG; Qi YB; Feng Y; Feng YH; Jia YL; Cheng FM; Feng GW; Jiang W; Shang WW
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(20):1538-1545. PubMed ID: 37246003
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland.
    Miettinen J; Lautenschlager I; Weissbach F; Wernli M; Auvinen E; Mannonen L; Lauronen J; Hirsch HH; Jalanko H
    Pediatr Transplant; 2019 Feb; 23(1):e13324. PubMed ID: 30447046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review.
    Demey B; Tinez C; François C; Helle F; Choukroun G; Duverlie G; Castelain S; Brochot E
    J Clin Virol; 2018 Dec; 109():6-12. PubMed ID: 30343190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for high-level BK viruria: a single center study in China.
    Xiong R; Ye H; Liu Z; Li X
    Virol J; 2020 Nov; 17(1):189. PubMed ID: 33243259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China.
    Li P; Cheng D; Wen J; Ni X; Xie K; Li X; Chen J
    BMC Nephrol; 2021 Oct; 22(1):328. PubMed ID: 34600511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
    Abudayyeh A; Hamdi A; Abdelrahim M; Lin H; Page VD; Rondon G; Andersson BS; Afrough A; Martinez CS; Tarrand JJ; Kontoyiannis DP; Marin D; Gaber AO; Oran B; Chemaly RF; Ahmed S; Abudayyeh I; Olson A; Jones R; Popat U; Champlin RE; Shpall EJ; Rezvani K
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BK polyomavirus in the urine for follow-up of kidney transplant recipients.
    Brochot E; Descamps V; Handala L; Faucher J; Choukroun G; Helle F; Castelain S; François C; Duverlie G; Touzé A
    Clin Microbiol Infect; 2019 Jan; 25(1):112.e1-112.e5. PubMed ID: 30076973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.
    Korth J; Widera M; Dolff S; Guberina H; Bienholz A; Brinkhoff A; Anastasiou OE; Kribben A; Dittmer U; Verheyen J; Wilde B; Witzke O
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29156086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples.
    Madden K; Janitell C; Sower D; Yang S
    Transpl Infect Dis; 2018 Oct; 20(5):e12952. PubMed ID: 29896858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
    van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
    J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Natural History of BK Polyomavirus and the Host Immune Response After Stem Cell Transplantation.
    Laskin BL; Denburg MR; Furth SL; Moatz T; Altrich M; Kleiboeker S; Lutzko C; Zhu X; Blackard JT; Jodele S; Lane A; Wallace G; Dandoy CE; Lake K; Duell A; Litts B; Seif AE; Olson T; Bunin N; Davies SM
    Clin Infect Dis; 2020 Dec; 71(12):3044-3054. PubMed ID: 31851312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.